|
TaKaRa
human lung primary adenocarcinomas Human Lung Primary Adenocarcinomas, supplied by TaKaRa, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human lung primary adenocarcinomas/product/TaKaRa Average 93 stars, based on 1 article reviews
human lung primary adenocarcinomas - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
MedChemExpress
inhibitor activity puri ed hyal1 protein Inhibitor Activity Puri Ed Hyal1 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/inhibitor activity puri ed hyal1 protein/product/MedChemExpress Average 93 stars, based on 1 article reviews
inhibitor activity puri ed hyal1 protein - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
Cusabio
human long palate Human Long Palate, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human long palate/product/Cusabio Average 93 stars, based on 1 article reviews
human long palate - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
Angio-Proteomie
a549 A549, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/a549/product/Angio-Proteomie Average 94 stars, based on 1 article reviews
a549 - by Bioz Stars,
2026-03
94/100 stars
|
Buy from Supplier |
|
Boster Bio
hyal1 Hyal1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hyal1/product/Boster Bio Average 90 stars, based on 1 article reviews
hyal1 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
OriGene
h460 H460, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/h460/product/OriGene Average 90 stars, based on 1 article reviews
h460 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Pharmaseed Ltd
a549 human non-small-cell lung carcinoma cells A549 Human Non Small Cell Lung Carcinoma Cells, supplied by Pharmaseed Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/a549 human non-small-cell lung carcinoma cells/product/Pharmaseed Ltd Average 90 stars, based on 1 article reviews
a549 human non-small-cell lung carcinoma cells - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
China Center for Type Culture Collection
large cell lung carcinoma cell line nci-h460 Large Cell Lung Carcinoma Cell Line Nci H460, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/large cell lung carcinoma cell line nci-h460/product/China Center for Type Culture Collection Average 90 stars, based on 1 article reviews
large cell lung carcinoma cell line nci-h460 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Takeda
human esophageal carcinoma cells Human Esophageal Carcinoma Cells, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human esophageal carcinoma cells/product/Takeda Average 90 stars, based on 1 article reviews
human esophageal carcinoma cells - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Korean Cell Line Bank
human nsclc cell line pc9 (egfr exon 19 deletion) ![]() Human Nsclc Cell Line Pc9 (Egfr Exon 19 Deletion), supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human nsclc cell line pc9 (egfr exon 19 deletion)/product/Korean Cell Line Bank Average 90 stars, based on 1 article reviews
human nsclc cell line pc9 (egfr exon 19 deletion) - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Human Protein Atlas
lung squamous cell carcinoma (lusc) ![]() Lung Squamous Cell Carcinoma (Lusc), supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/lung squamous cell carcinoma (lusc)/product/Human Protein Atlas Average 90 stars, based on 1 article reviews
lung squamous cell carcinoma (lusc) - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Flow Laboratories
human lung carcinoma cell line a549 ![]() Human Lung Carcinoma Cell Line A549, supplied by Flow Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human lung carcinoma cell line a549/product/Flow Laboratories Average 90 stars, based on 1 article reviews
human lung carcinoma cell line a549 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Translational Cancer Research
Article Title: Chronic nicotine exposure affects programmed death-ligand 1 expression and sensitivity to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer
doi: 10.21037/tcr.2019.05.02
Figure Lengend Snippet: Morphology of cells after treatment with gefitinib in PC9 and PC9/N cells. Cells were seeded in six-well culture plates, and after 24 hrs, the cells were treated with gefitinib (0, 0.1, or 1 µM) for 48 hrs. Cells were photographed under a phase contrast inverted microscope. Cells were stained with Wright and Giemsa (original magnification 200×). These results are representative of technical triplicate.
Article Snippet:
Techniques: Inverted Microscopy, Staining
Journal: Translational Cancer Research
Article Title: Chronic nicotine exposure affects programmed death-ligand 1 expression and sensitivity to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer
doi: 10.21037/tcr.2019.05.02
Figure Lengend Snippet: Cell viability assay for PC9 and PC9/N cells cultured in the presence of gefitinib. Cell growth inhibition in response to gefitinib was evaluated by using the MTT assay. Cells were treated with the indicated concentrations of gefitinib and cell viability was determined 48 hrs later. There are mean of independent triplicate experiments. The data are presented as means ± SEM from technical triplicate. PC9/N: nicotine (1 µM) expose for 3 months in PC9 cells. *, P<0.05; **, P<0.01 and ***, P<0.001 compared with PC9 + gefitinib 0 µM. ## , P<0.01 and ### , P<0.001 compared with PC9/N + gefitinib 0 µM. $ , P<0.05 between two cells with gefitinib 0.01 µM. Data are presented as mean ± standard error of the mean (SEM). SEM, standard error.
Article Snippet:
Techniques: Viability Assay, Cell Culture, Inhibition, MTT Assay
Journal: Translational Cancer Research
Article Title: Chronic nicotine exposure affects programmed death-ligand 1 expression and sensitivity to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer
doi: 10.21037/tcr.2019.05.02
Figure Lengend Snippet: The mRNA expression of cells after treatment with gefitinib in PC9 and PC9/N cells. Cells were treated with gefitinib (0, 0.1, or 1 µM) for 48 hrs, and the mRNA expressions of α1-nAchR, and PD-L1 were examined by quantitative reverse transcription (qRT)-PCR (A) and RT-PCR (B). These results are representative of technical triplicate. *, P<0.05 and ***, P<0.001 compared with PC9 cells. ### , P<0.001 compared with PC9 cells + gefitinib 0 µM and $$$ , P<0.001 compared with PC9/N + gefitinib 0 µM. nAchR, nicotinic acetylcholine receptors; PD-L1, programmed death ligand 1.
Article Snippet:
Techniques: Expressing, Reverse Transcription, Quantitative RT-PCR, Reverse Transcription Polymerase Chain Reaction
Journal: Translational Cancer Research
Article Title: Chronic nicotine exposure affects programmed death-ligand 1 expression and sensitivity to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer
doi: 10.21037/tcr.2019.05.02
Figure Lengend Snippet: The protein expression levels of cells after treatment with gefitinib in PC9 and PC9/N cells. The cells were cultured with gefitinib (0, 0.1, or 1 µM) for 48 hrs, and EGFR, mTOR, AKT, PD-L1 and α1-nAchR was detected by Western blot. β-actin was used as an internal control. Western blot was quantified by densitometry and ImageJ. These results are representative of technical triplicate. EGFR, epidermal growth factor receptor; PD-L1, programmed death ligand 1; nAchR, nicotinic acetylcholine receptors.
Article Snippet:
Techniques: Expressing, Cell Culture, Western Blot, Control
Journal: Translational Cancer Research
Article Title: Chronic nicotine exposure affects programmed death-ligand 1 expression and sensitivity to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer
doi: 10.21037/tcr.2019.05.02
Figure Lengend Snippet: Immunofluorescence staining of PD-L1 and phosphorylation of EGFR in PC9 and PC9/N cells treated with 0.1 µM gefitinib. The localizations of PD-L1 and p-EGFR (green signal; Alexa488) in PC9 and PC9/N cells were shown by immunofluorescence counterstained with DAPI (blue signal) and analyzed by confocal microscopy (original magnification 400×). These results are representative of technical triplicate. DAPI, 4',6-diamidino-2-phenylindole; EGFR, epidermal growth factor receptor.
Article Snippet:
Techniques: Immunofluorescence, Staining, Phospho-proteomics, Confocal Microscopy
Journal: Translational Cancer Research
Article Title: Chronic nicotine exposure affects programmed death-ligand 1 expression and sensitivity to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer
doi: 10.21037/tcr.2019.05.02
Figure Lengend Snippet: Overall proportion of PD-L1 TPS expression according to pack-year in NSCLC patients harboring activating EGFR mutation. Heavy smokers ( ≥ 30 PY) tended to have higher expression ( ≥ 50% PD-L1 TPS) than never and light smokers, however, Fisher exact test showed no statistical significance (P value =0.628). PD-L1, programmed death ligand 1; TPS, tumor proportion score; NSCLC, non-small cell lung cancer; EGFR, epidermal growth factor receptor; PY, pack-year.
Article Snippet:
Techniques: Expressing, Mutagenesis